In terms of the mucin phenotype, samples with the intestinal phenotype predominantly showed downregulation of CLDN18.2, suggesting that the loss of CLDN18 is involved in the pathogenesis of tumours of the intestinal phenotype and indicating that its expression can be used as a marker for the gastric phenotype (28, 41, 46). This evidence concerns the gene CLDN18 and neoplasm.